Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Kine Sciences Logo
Kine Sciences Growth Score
83
CB Rank
499471
Heat Score
66
Kine Sciences is a biotechnology company that develops ultra-peptide medicines to treat chronic immune diseases.
Founded
obfuscation
PrivateVenture - Series Unknown Seoul, Seoul-t'ukpyolsi, South Korea1-10 kinesciences.com
Biotechnology
Life Science
Pharmaceutical
Overview

Kine Sciences
Growth Score
83
Heat Score
66

Growth Score83
-4 pts
in past quarter
Heat Score 66
-11 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Kine Sciences

CB Rank
499471
Kine Sciences is a biotechnology company that develops ultra-peptide medicines to treat chronic immune diseases.
Founded
obfuscation
PrivateVenture - Series Unknown Seoul, Seoul-t'ukpyolsi, South Korea1-10 kinesciences.com
Biotechnology
Life Science
Pharmaceutical

Funding Rounds

Venture - Series Unknown
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation

Details

Legal Name Bio Pep Co., Ltd.
Operating Status Active
Company Type For Profit
Phone Number +82 2 553 3120
Contact Email info@kinesciences.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

KINE-101A
A peptide drug candidate for treating rheumatoid arthritis by modulating immune cell responses.
KINE-101B
A peptide drug candidate aimed at treating inflammatory bowel disease by controlling immune responses.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - Kine Sciences Logo
Venture Round - Kine Sciences
1
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Kine Sciences Logo
Venture Round - Kine Sciences
1
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Kine Sciences Logo
Venture Round - Kine Sciences
1
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Kine Sciences Logo
Venture Round - Kine Sciences
1
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Kine Sciences Logo
Venture Round - Kine Sciences
1
obfuscation
— Venture - Series Unknown

Funding Rounds

Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - Kine Sciences Logo
Venture Round - Kine Sciences
1
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Kine Sciences Logo
Venture Round - Kine Sciences
1
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Kine Sciences Logo
Venture Round - Kine Sciences
1
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Kine Sciences Logo
Venture Round - Kine Sciences
1
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Kine Sciences Logo
Venture Round - Kine Sciences
1
obfuscation
— Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
STIC Ventures Logo
STIC Ventures
—
Venture Round - Kine Sciences Logo
Venture Round - Kine Sciences
—
STIC Ventures Logo
STIC Ventures
—
Venture Round - Kine Sciences Logo
Venture Round - Kine Sciences
—
STIC Ventures Logo
STIC Ventures
—
Venture Round - Kine Sciences Logo
Venture Round - Kine Sciences
—
STIC Ventures Logo
STIC Ventures
—
Venture Round - Kine Sciences Logo
Venture Round - Kine Sciences
—
STIC Ventures Logo
STIC Ventures
—
Venture Round - Kine Sciences Logo
Venture Round - Kine Sciences
—
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10
News
Technology
View Tech Report

Active Website Tech Count

9Kine Sciences is actively using 9 technologies for its website, according to BuiltWith. These include Common Crawl, Content Delivery Network, and  CommonCrawl Top 5m.

Total IP

5The intellectual property of Kine Sciences includes 5 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Kine Sciences's headquarters? Kine Sciences is located in Seoul, Seoul-t'ukpyolsi, South Korea.Who invested in Kine Sciences? Kine Sciences has 2 investors including STIC Ventures and  HB Investment.When was the last funding round for Kine Sciences? Kine Sciences closed its last funding round on
obfuscation
from a Venture - Series Unknown round.Who are Kine Sciences's competitors? Alternatives and possible competitors to Kine Sciences may include Eli Lilly, Gilead Sciences, and  AbbVie.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(3ff49e4 1)
|